EP Patent

EP1894559A1 — Means to solubilise steroids for inhalation

Assigned to PARI Pharma GmbH · Expires 2008-03-05 · 18y expired

What this patent protects

Sterile compositions for administration as aerosols are described. They contain an active agent which is a poorly water-soluble corticosteroid, preferably budesonide, fluticasone, mometasone, or ciclesonide, and a cyclodextrin. The compositions are suitable for oral or nasal inha…

USPTO Abstract

Sterile compositions for administration as aerosols are described. They contain an active agent which is a poorly water-soluble corticosteroid, preferably budesonide, fluticasone, mometasone, or ciclesonide, and a cyclodextrin. The compositions are suitable for oral or nasal inhalation. They are particularly useful for the pulmonary administration of corticosteroids using common jet or electronic nebulisers.

Drugs covered by this patent

Patent Metadata

Patent number
EP1894559A1
Jurisdiction
EP
Classification
—
Expires
2008-03-05
Drug substance claim
No
Drug product claim
No
Assignee
PARI Pharma GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.